Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Ovarian Carcinosarcoma × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Sarcoma 8 Osteosarcoma 5 Bone Neoplasms 5 Neurofibrosarcoma 3 Liposarcoma 3 Leiomyosarcoma 3 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Sarcoma, Alveolar Soft Part 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Gliosarcoma 2 Gastrointestinal Stromal Tumors 2 Fibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Sarcoma, Clear Cell 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Perivascular Epithelioid Cell Neoplasms 1 Ovarian Neoplasms 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡